PTC Therapeutics Inc banner

PTC Therapeutics Inc
SWB:BH3

Watchlist Manager
PTC Therapeutics Inc Logo
PTC Therapeutics Inc
SWB:BH3
Watchlist
Price: 59.5 EUR 3.48% Market Closed
Market Cap: €4.5B

Intrinsic Value

The intrinsic value for PTC Therapeutics Inc (BH3) under the Base Case is 52.87 EUR. Compared with the current market price of 59.5 EUR, the stock appears Overvalued by 11% .

BH3 Intrinsic Value
52.87 EUR
Overvaluation 11%
Intrinsic Value
Price €59.5
Bear Case
Base Case
Bull Case
Monitor BH3
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €42.3
Get notified when the price drops into your buy zone
Current Price €59.5
Intrinsic Value €52.87
Margin of Safety 20% €42.3
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about BH3?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is BH3 valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for PTC Therapeutics Inc.

Explain Valuation
Alternatives to BH3

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

PTCT Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one BH3 stock?

The intrinsic value for PTC Therapeutics Inc (BH3) under the Base Case is 52.87 EUR.

Is BH3 stock undervalued or overvalued?

Compared with the current market price of 59.5 EUR, the stock appears Overvalued by 11% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett